Literature DB >> 2395181

Loss of viability after disulfiram treatment without preceding depletion of intracellular GSH.

Y Ohno1, K Hirota, T Kawanishi, A Takanaka.   

Abstract

Effects of disulfiram (DSF) on freshly isolated hepatocytes were examined. Its effects on the cellular reduced form of glutathione (GSH) were triphasic; GSH decreased instantly after the addition of DSF, returned to subnormal levels within 30 min, and then declined gradually. The initial decrease in GSH after DSF treatment and the subsequent recovery of GSH were accompanied by an increase and decrease in the oxidized form of glutathione (GSSG), respectively. Decreases in cell viability brought about by 0.4 mM of DSF were correlated with the later gradual decrease in GSH. The loss of viability by DSF treatment seemed to appear when the initial GSH levels became lower than approximately 5 nmole/10(6) cells. Hepatocyte toxicity of DSF was potentiated by diethylmaleate (GSH depletor) and inhibited by N-acetylcysteine (GSH biosynthesis precursor). 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), an inhibitor of GSH reductase, inhibited the GSH recovery and potentiated the toxicity. Respiration of hepatocytes was also inhibited by DSF. Free sulfhydryl groups other than GSH showed similar changes to those of GSH. From these results, it seemed that DSF reacted with cellular GSH and other free sulfhydryl groups to form diethyldithiocarbamate and GSSG, GSSG was reduced back to GSH by glutathione reductase, and the decrease in the viability was dependent on the initial loss of GSH.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2395181     DOI: 10.2131/jts.15.63

Source DB:  PubMed          Journal:  J Toxicol Sci        ISSN: 0388-1350            Impact factor:   2.196


  2 in total

1.  Effect of tetrakis-mu-3,5-diisopropylsalicylatodiaquodicopper(II) on the status of reduced glutathione in freshly isolated hepatocytes.

Authors:  M F Khan; Y Ohno; A Takanaka
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

2.  The repositioned drugs disulfiram/diethyldithiocarbamate combined to benznidazole: Searching for Chagas disease selective therapy, preventing toxicity and drug resistance.

Authors:  Juliana Almeida-Silva; Diego Silva Menezes; Juan Mateus Pereira Fernandes; Márcio Cerqueira Almeida; Deyvison Rhuan Vasco-Dos-Santos; Roberto Magalhães Saraiva; Alessandra Lifsitch Viçosa; Sandra Aurora Chavez Perez; Sônia Gumes Andrade; Ana Márcia Suarez-Fontes; Marcos André Vannier-Santos
Journal:  Front Cell Infect Microbiol       Date:  2022-07-29       Impact factor: 6.073

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.